相关实验视频
远程监测和高血压控制的自我管理 (TASMINH2):一个随机对照试验
Richard J McManus1, Jonathan Mant, Emma P Bray
1Primary Care Clinical Sciences, University of Birmingham and National Institute for Health Research (NIHR) National School for Primary Care Research, Birmingham, UK. r.j.mcmanus@bham.ac.uk
Lancet (London, England)
|July 13, 2010
概括
高血压的自我管理,包括家庭血压监测和远程监测,与通常护理相比,患者的血压控制显著改善. 这种方法为初级保健机构管理高血压提供了一个有价值的新策略.
科学领域:
- 心血管医学 心血管医学
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 有效的血压控制对于预防心血管疾病至关重要,但往往很难实现.
- 从历史上看,高血压管理主要由医疗保健专业人员领导.
研究的目的:
- 评估患者对高血压的自我管理的有效性,包括自我监测和远程监测,与常规护理相比.
- 为了确定是否自我管理导致更好的血压控制在不充分控制高血压的个体.
主要方法:
- 这是一项随机对照试验,涉及527名高血压 (血压>140/90毫米) 的患者 (年龄在35-85岁).
- 参与者被随机分配1:1到一个自我管理组 (自我监测,自我定位,远程监测) 或一个通常的护理组.
- 主要终点是6个月和12个月平均静脉压的变化.
主要成果:
- 与常规护理组相比,自我管理组在6个月 (12.9毫米平与9.2毫米平) 和12个月 (17.6毫米平与12.2毫米平) 后,表现出缩血压的较大降低.
- 在两个时间点上,两组之间静脉压降低的差异在统计学上是显著的 (p=0.013在6个月,p=0.0004在12个月).
- 在自我管理组 (32%) 报告的腿部胀比在常规护理组 (22%) 更频繁.
结论:
- 通过远程监测增强的高血压患者自我管理是改善初级保健中血压控制的有效策略.
- 这种方法代表了高血压管理的重大进步,赋予患者权力,并可能改善心血管结果.
相关概念视频
Hypertension V: Nursing Management
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Errors occurring during blood pressure monitoring
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...